Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$1.01 USD
+0.02 (2.31%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.99 -0.02 (-1.98%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2025
Time: -- |
9/2025 | $-0.09 | 0.00% |
Earnings Summary
For their last quarter, Predictive Oncology (POAI) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 144.44%. Look out for POAI's next earnings release expected on November 11, 2025. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year increase of 75%.
Earnings History
Price & Consensus
Zacks News for POAI
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
POAI: What are Zacks experts saying now?
Zacks Private Portfolio Services